Multi-phase fluid volume compensation: BayerRecent Research Landscape
Inaccurate contrast delivery and air embolisms during vascular access increase patient risk and diagnostic failure. This lever synchronizes transition phases and line prefilling to ensure precise bolus timing and safety.
What technical problems is Bayer addressing in Multi-phase fluid volume compensation?
Inaccurate fluid delivery volume
(37)evidences
Inaccurate identification or timing of fluid transitions during injection poses risks to patient safety and diagnostic accuracy. Preventing the delivery of incorrect fluid types or air ensures procedural integrity.
Inaccurate fluid delivery volumes
(20)evidences
Unintended reverse flow and pressure surges in multi-phase injection systems cause cross-contamination and mechanical failure. Preventing these instabilities ensures sterile integrity and precise dosing.
Inaccurate fluid volume delivery
(15)evidences
Mechanical misalignment and contamination risks during syringe attachment lead to delivery failure or patient safety hazards. Eliminating these risks ensures consistent pressure integrity and sterile fluid paths.
Cross contamination risk
(8)evidences
Exposed connection points in medical delivery systems are susceptible to pathogen ingress. Preventing microbial entry reduces healthcare-associated infections and ensures patient safety during repeated access.